Similar articles

• Post-marketing surveillance of new drugs.

  Buckley EG. Buckley EG. J R Coll Gen Pract. 1987 Aug;37(301):337-8. J R Coll Gen Pract. 1987. PMID: 3448222 Free PMC article. No abstract available.
• Postmarketing surveillance of adverse reactions to drugs.

  Rawlins MD. Rawlins MD. Br Med J (Clin Res Ed). 1984 Mar 24;288(6421):879-80. doi: 10.1136/bmj.288.6421.879. Br Med J (Clin Res Ed). 1984. PMID: 6423125 Free PMC article. No abstract available.
• Postmarketing surveillance of adverse reactions to drugs.

  Inman WHW. Inman WHW. Br Med J (Clin Res Ed). 1984 Apr 14;288(6424):1155-6. doi: 10.1136/bmj.288.6424.1155. Br Med J (Clin Res Ed). 1984. PMID: 6424767 Free PMC article. No abstract available.
• Techniques of postmarketing surveillance. An overview.

  Carson JL, Strom BL. Carson JL, et al. Med Toxicol. 1986 Jul-Aug;1(4):237-46. doi: 10.1007/BF03259840. Med Toxicol. 1986. PMID: 3537618 Review. No abstract available.
• Evaluating and monitoring the safety and efficacy of drug therapy and surgery.

  Stolley PD, Strom BL. Stolley PD, et al. J Chronic Dis. 1986;39(12):1145-55. doi: 10.1016/0021-9681(86)90145-1. J Chronic Dis. 1986. PMID: 3539972 Review. No abstract available.